GLS2 - glutaminase 2 Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 100686499
GLS2 Products (7)
| mRNA | Protein | Name |
|---|---|---|
| XM_038679023.1 | XP_038534951.1 | glutaminase liver isoform, mitochondrial isoform X2 |
| XM_038679026.1 | XP_038534954.1 | glutaminase liver isoform, mitochondrial isoform X5 |
| XM_038679022.1 | XP_038534950.1 | glutaminase liver isoform, mitochondrial isoform X1 |
| XM_038679028.1 | XP_038534956.1 | glutaminase liver isoform, mitochondrial isoform X7 |
| XM_038679024.1 | XP_038534952.1 | glutaminase liver isoform, mitochondrial isoform X3 |
| XM_038679027.1 | XP_038534955.1 | glutaminase liver isoform, mitochondrial isoform X6 |
| XM_038679025.1 | XP_038534953.1 | glutaminase liver isoform, mitochondrial isoform X4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
glutaminase liver isoform, mitochondrial |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-12248 | Telaglenastat | 99.82% | Phase 2 | |
| HY-12248A | Telaglenastat hydrochloride | 98.03% | Phase 2 | |
| HY-P2760 | Glutaminase | Control | / | Phase 2 |
| HY-103671 | IPN60090 | Inhibitor | 98.96% | Phase 1 |
| HY-103671A | IPN60090 dihydrochloride | Inhibitor | 99.68% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-151434 | GLS1 Inhibitor-6 | / | Unkown | |
| HY-RS05503 | GLS2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17808 | Gls2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24276 | Gls2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service